KR840000901A - 옥센돌론 수성 현탁제의 제조방법 - Google Patents

옥센돌론 수성 현탁제의 제조방법 Download PDF

Info

Publication number
KR840000901A
KR840000901A KR1019820003686A KR820003686A KR840000901A KR 840000901 A KR840000901 A KR 840000901A KR 1019820003686 A KR1019820003686 A KR 1019820003686A KR 820003686 A KR820003686 A KR 820003686A KR 840000901 A KR840000901 A KR 840000901A
Authority
KR
South Korea
Prior art keywords
oxendolone
preparing
aqueous suspension
esters
note
Prior art date
Application number
KR1019820003686A
Other languages
English (en)
Other versions
KR880001806B1 (ko
Inventor
에쓰노스께 노다 (외 2)
Original Assignee
구라바야시 이꾸시로
다께다 야꾸힝 고오교 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구라바야시 이꾸시로, 다께다 야꾸힝 고오교 가부시끼 가이샤 filed Critical 구라바야시 이꾸시로
Publication of KR840000901A publication Critical patent/KR840000901A/ko
Application granted granted Critical
Publication of KR880001806B1 publication Critical patent/KR880001806B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

내용 없음

Description

옥센돌론 수성 현탁제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 비이온 계면활성제 0.05~1.0w/v% 및 파라옥시벤조산 에스테르류 0.01~0.25w/v%을 함유시킴을 특징으로 하는 옥센돌론 또는 그의 에스테르류의 안정화된 수성 현탁제의 제조법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8203686A 1981-08-18 1982-08-17 옥센돌론 수성 현탁제의 제조방법 KR880001806B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP129517 1981-08-18
JP129517/1981 1981-08-18
JP56129517A JPS5832899A (ja) 1981-08-18 1981-08-18 オキセンドロン水性懸濁剤

Publications (2)

Publication Number Publication Date
KR840000901A true KR840000901A (ko) 1984-03-26
KR880001806B1 KR880001806B1 (ko) 1988-09-19

Family

ID=15011450

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8203686A KR880001806B1 (ko) 1981-08-18 1982-08-17 옥센돌론 수성 현탁제의 제조방법

Country Status (13)

Country Link
US (1) US4462996A (ko)
EP (1) EP0072662B1 (ko)
JP (1) JPS5832899A (ko)
KR (1) KR880001806B1 (ko)
AR (1) AR230730A1 (ko)
CA (1) CA1176983A (ko)
DE (1) DE3263754D1 (ko)
ES (1) ES8403719A1 (ko)
GR (1) GR76258B (ko)
HK (1) HK23888A (ko)
MY (1) MY8700654A (ko)
PT (1) PT75435B (ko)
SG (1) SG110187G (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
PT1675573E (pt) * 2003-10-23 2008-12-30 Otsuka Pharma Co Ltd Formulação de iripiprazole injectável estéril de libertação controlada e um processo para a sua preparação
EP2279727A3 (en) * 2005-09-15 2011-10-05 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
RU2483711C2 (ru) * 2007-07-31 2013-06-10 Оцука Фармасьютикал Ко., Лтд. Способы получения суспензии арипипразола и лиофилизированного состава

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
JPS4832643A (ko) * 1971-09-02 1973-05-01
JPS4966815A (ko) * 1972-10-25 1974-06-28

Also Published As

Publication number Publication date
US4462996A (en) 1984-07-31
PT75435A (pt) 1982-09-01
CA1176983A (en) 1984-10-30
JPS6361957B2 (ko) 1988-11-30
EP0072662B1 (en) 1985-05-22
MY8700654A (en) 1987-12-31
JPS5832899A (ja) 1983-02-25
GR76258B (ko) 1984-08-04
DE3263754D1 (en) 1985-06-27
EP0072662A3 (en) 1983-08-24
PT75435B (pt) 1985-05-31
AR230730A1 (es) 1984-06-29
ES515057A0 (es) 1984-04-01
ES8403719A1 (es) 1984-04-01
EP0072662A2 (en) 1983-02-23
SG110187G (en) 1988-05-20
HK23888A (en) 1988-04-08
KR880001806B1 (ko) 1988-09-19

Similar Documents

Publication Publication Date Title
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR830009084A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR840000901A (ko) 옥센돌론 수성 현탁제의 제조방법
KR860001045A (ko) 메발로노락톤의 나프틸 동족체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
KR840002901A (ko) 세라펩타제를 안정화 세라펩타제를 안정화 시키는 방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR830008990A (ko) 2-아미노-3-(할로벤조일)-메틸페닐아세트산 유도체의 제조방법
KR830004414A (ko) 마이코페놀산 유도체의 제조방법
KR850001766A (ko) 무라밀디펩타이드 활성 에스테르 유도체의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR850001737A (ko) N,n-디메틸-2-클로로-5-[3-메틸-2-(페닐이미노)-4-티아졸린-4-일]-페닐설폰아미이드의 포합화합물의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR830010091A (ko) 구연산 나프티드로푸릴의 제조방법
KR860004008A (ko) 부타놀유도체의 제법
KR880011102A (ko) 2-알콜시카르보닐-4-(4-피리딜)시클로헥사논 및 그 제조방법
KR890003660A (ko) 4-(4-히드록시페닐)-시클로헥산올의 제조방법
KR830005179A (ko) 아세트 아닐리드의 제조방법
CA1270605C (en) NON-FORTIFIED LIQUID COMPOSITION FOR THE COATING OF PAPER, AND ITS PREPARATION
KR830005192A (ko) 2,4-디아미노-5-설파모일 벤젠 설폰산의 제조방법
KR870008861A (ko) 트리아졸린-5-온 유도체의 제조방법
KR830004286A (ko) 디벤조 티에핀 프로피온아미드유도체의 제조방법
KR880001634A (ko) 피로글루타미드 유도체 그 제조방법